Search results for "molecular microbiology"
Selected Filters:
Labmatrix™
BioFortis IncLabmatrix™ is a web-based software application for management of clinical, specimen and molecular assay data. With the ability to integrate these data sets in a tightly linked, highly annotated manner, Labmatrix™ is being used by multiple customers in the biopharmaceutical industry, academic and government research institutes for biomarker discovery, biobanking and translational clinical and genetic research. As researchers…
Non-Esterified Fatty Acids (NEFA) Assay
Randox Laboratories Ltd.Non-Esterified Fatty Acids (NEFA) are molecules released from triglycerides which are transported in the blood bound to albumin. They contribute only a small proportion of the body’s fat, but provide a large part of its energy. Measurement of NEFA is particularly important in diabetes where insulin deficiency results in the metabolism of fat. Randox NEFA offers laboratories a high quality test for results you can rely on.Non-…
BD Unveils Latest Diagnostic Innovations at ECCMID
New Synapsys microbiology informatics solution will be demonstrated at the event
Bio-Rad Launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 analysis software enable high-quality and affordable single-cell transcription and gene expression to support molecular biology, oncology, and drug discovery research
How Protein - Small Molecule Interactions Could Reveal New Therapeutic Targets
Dr. Ivan Cornella-Taracido, of Cedilla Therapeutics, discusses his work looking for therapeutic targets by harnessing protein homeostasis, and shares his insights into the future of drug discovery
Single Molecule MicroRNA Technology Proves Useful for Liver Toxicity Detection
Breakthrough research published in PLOS ONE demonstrates quantitative, PCR-free detection of microRNA
Overcoming Challenges in the Molecule and Cell Line Development Process
Lokon Pharma and Affibody initiate a collaboration to develop novel cancer therapeutics
The partnership aims to combine oncolytic viruses with Affibody® molecules
















